<scp>HMGB1</scp> blood levels and neurological outcomes after traumatic brain injury: Insights from an exploratory study
Irma Wati Ngadimon(Monash University Malaysia), Wing Loong Cheong(Monash University Malaysia), Ángel Aledo‐Serrano, Jegan Thanabalan(University Kebangsaan Malaysia Medical Centre), Ching Soong Khoo(University Kebangsaan Malaysia Medical Centre), Hui Jan Tan(National University of Malaysia), Farizal Fadzil(Hospital Kuala Lumpur), Mohd. Farooq Shaikh(University of Mumbai), Alina Arulsamy(Monash University Malaysia), Nor Syazwani Chamhuri(Hospital Kuala Lumpur), Devi Mohan(Monash University Malaysia), Nursyazwana Zolkafli(Hospital Kuala Lumpur), Yu Mey Lee(National University of Malaysia)
Cited by 5
Related Papers
HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
|Frontiers in Neuroscience|2018|318
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
|Cells|2020|257
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling
|European Journal of Pharmacology|2019|175
Alcohol Use Disorder, Neurodegeneration, Alzheimer’s and Parkinson’s Disease: Interplay Between Oxidative Stress, Neuroimmune Response and Excitotoxicity
|Frontiers in Cellular Neuroscience|2020|160
Alcohol, Aggression, and Violence: From Public Health to Neuroscience
|Frontiers in Psychology|2021|144